Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials

Journal of Law, Medicine and Ethics 40 (4):856-864 (2012)
  Copy   BIBTEX

Abstract

The article focuses on issues relating to occupational exposures of researchers and lab workers, and exposures of bystanders such as health care workers and family members during HSR using nanomaterials. Such third-party exposures give rise to unique challenges relating to oversight as well as exposures to worker groups not previously studied. Given the current state of knowledge regarding health risks from such exposures, a more precautionary approach to oversight seems advisable

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,891

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Assessing Exposures.Jon Williamson, Beth Shaw, Federica Russo, Charles Norell, Michael Kelly, Phyllis Illari, Brendan Clarke, Michael Wilde, Christian Wallmann & Veli-Pekka Parkkinen - 2018 - In Veli-Pekka Parkkinen, Christian Wallmann, Michael Wilde, Brendan Clarke, Phyllis Illari, Michael P. Kelly, Charles Norell, Federica Russo, Beth Shaw & Jon Williamson (eds.), Evaluating evidence of mechanisms in medicine. Dordrecht, Netherlands: Springer.

Analytics

Added to PP
2013-03-01

Downloads
30 (#520,056)

6 months
8 (#506,022)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references